404 Phase I study of MEDI-575, a fully human monoclonal...

European Journal of Cancer Supplements 2010 Vol. 8; Iss. 7

404 Phase I study of MEDI-575, a fully human monoclonal antibody targeting PDGFR-alpha in subjects with advanced solid tumors

R. Lechleider, C. Becerra, M. Liang, R. Narwal, L. Shi, P. Conkling, M. Galsky, R. Jotte, H. Wu, N.J. Vogelzang
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
8
Year:
2010
Language:
english
DOI:
10.1016/s1359-6349(10)72111-x
File:
PDF, 47 KB
english, 2010
Conversion to is in progress
Conversion to is failed